Home › Mitral Valve Insufficiency › NCT04919980
TVMR With the INNOVALVE System Trial - Early Feasibility Study
Recruiting
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Clinically significant, symptomatic mitral regurgitation * High risk for open-heart surgery * Meets anatomical criteria Exclusion Criteria: * Unsuitable anatomy * Patient is inoperable * EF\<25%
About the study
Study to evaluate the safety and performance of the INNOVALVE system
What is being tested
- INNOVALVE system (device)
Sponsor: Edwards Lifesciences · Participants: 85 · Started: Sep 1, 2022
Contact the study team
- TMTT Clinical · Phone: (949) 250-2500
Official record on ClinicalTrials.gov — NCT04919980
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.